$6 Million in Gifts Launches UVA Biotech Innovation Fund
Three generous philanthropists have donated gifts totaling $6 million to establish the UVA Biotech Innovation Fund. This fund will provide long-term support for the UVA SPARK Innovative Medicines program, helping speed the development of new treatments and cures.
UVA's inaugural SPARK Tank competition, held this August, attracted strong interest from researchers across the university and resulted in the selection of several high-potential projects for targeted support. This support aims to help the projects survive what is known as the "translational valley of death" -- the critical gap between discovery and clinical application, when many promising projects fail.
The new fund will ensure that future competition cohorts have access to the financial, project management and regulatory resources needed to transform science into medicines.
The SPARK program is a key part of UVA's Paul and Diane Manning Institute of Biotechnology's efforts to accelerate how quickly UVA's cutting-edge scientific discoveries can be translated into medicines. The institute aims to do this by fostering innovation, creating a biotechnology ecosystem via new jobs and companies, and educating the next generation of biotechnology leaders, with the ultimate goal of benefiting patients across Virginia and beyond.